Part 369 — Interpretative Statements Re Warnings on Drugs and Devices for Over-the-Counter Sale
Current through Sep 8, 2026
Authority: 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.
Source: 39 FR 11745, Mar. 29, 1974, unless otherwise noted.
Editorial Note: Nomenclature changes to part 369 appear at 69 FR 13717, Mar. 24, 2004.
Sections
- § 369.1 Purpose of issuance.
- § 369.2 Definitions.
- § 369.3 Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).
- § 369.4 Warnings suggested for drugs by formal or informal statements of policy.
- § 369.6 [Reserved]
- § 369.7 Warnings required by official compendia.
- § 369.8 Warning statements in relation to conditions for use.
- § 369.9 General warnings re accidental ingestion by children.
- § 369.10 Conspicuousness of warning statements.
- § 369.20 Drugs; recommended warning and caution statements.
- § 369.21 Drugs; warning and caution statements required by regulations.